News | January 19, 2015

A simple technique may be most effective in preventing heart disease after radiation therapy for breast cancer

radiation therapy, breast cancer, breath hold, heart, clinical study

January 19, 2015 — Women who have breast cancer on their left side present a particular challenge to radiation oncologists. Studies have shown that the risk of heart disease is higher in this group of women after radiation treatment because it can be difficult to ensure that a sufficient dose of radiation is delivered to the left breast while adequately shielding the heart from exposure. New research shows a woman who holds her breath during radiation pulses can greatly reduce radiation exposure to the heart.

“Radiation therapy is commonly prescribed to patients with breast cancer following surgery as a component of first-line therapy,” said first author Harriet Eldredge-Hindy, M.D., a chief resident and researcher in the department of radiation oncology at Thomas Jefferson University. “We wanted to determine how effective breath-hold could be in shielding the heart from extraneous radiation exposure during treatment of the left breast.”

Recent studies have shown women with cancer in the left breast are at higher risk of heart disease, and that the risk increases proportionately with the dose of radiation the heart is exposed to during treatment. A number of techniques have been developed to reduce exposure to the heart including prone positioning, intensity-modulated radiation therapy (IMRT) and accelerated partial breast irradiation. The breath-hold technique allows doctors to monitor a patient’s breath for the position that shifts the heart out of the range of the radiation beam.

In the largest prospective study to date, following women for eight years post-treatment, 81 women were asked to hold their breath during radiation treatment for breast cancer– a process that was repeated until therapeutic dose was reached. The researchers found that patients capable of holding their breath over the course of treatment had a 90-percent disease-free survival, and a 96-percent overall survival, with a median reduction in radiation dose to the heart of 62 percent. The findings were published online in the journal Practical Radiation Oncology.

“Given that this technique helps to shield the heart during radiation treatment for breast cancer,” said Rani Anne, M.D., associate professor of radiation oncology at Thomas Jefferson University and senior author on the study, “we routinely offer breast cancer treatment with the breath-hold technique at Jefferson.”

Additional work presented at the 2014 American Society for Radiation Oncology in San Francisco carried the work further in order to determine whether protection from the additional radiation dose in fact translated to a reduction in ischemic heart disease. Anne, together with Eldredge-Hindy, showed that this same cohort of patients will likely have a reduced risk of ischemic heart disease after 10 years. The study showed that patients who held their breath during radiation therapy had only a 1.4-percent rate of ischemic heart disease after eight years of follow up and an estimated rate of 3.6 percent after 10 years.

For more information: www.jefferson.edu


Related Content

News | PET Imaging

Jan. 26, 2026 — Nuclidium, a clinical-stage radiopharmaceutical company developing a proprietary copper-based ...

Time January 27, 2026
arrow
News | Radiology Imaging

Jan. 21, 2026 — Cathpax, a spin-off of the Lemer Pax group that designs, develops and commercializes team-wide, full ...

Time January 22, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Jan. 20, 2026 — Hyperfine, the developer of the first FDA-cleared AI-powered portable MRI system for the brain — the ...

Time January 20, 2026
arrow
News | Mammography

Jan. 16, 2026 — Vega Imaging Informatics has announced the successful curation of the world’s largest digital breast ...

Time January 19, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — VizMark has received U.S. Food and Drug Administration FDA 510k clearance for VM1, a non-metal visual ...

Time January 19, 2026
arrow
News | Radiation Therapy

Jan. 16, 2026 — Elekta has announced that its Elekta Evo* CT-Linac has received 510(k) clearance from the U.S. Food and ...

Time January 16, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — Susan G. Komen, the world’s leading breast cancer organization commends Assemblymember Lori Wilson (D ...

Time January 16, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — iSono Health has announced the commercial launch of ATUSA, an FDA-cleared, wearable and automated 3D ...

Time January 14, 2026
arrow
News | Breast Imaging

Dec. 16, 2025 — Hologic, Inc, a medical technology company dedicated to improving women’s health, recently announced new ...

Time December 16, 2025
arrow
News | Radiopharmaceuticals and Tracers

Dec. 11, 2025 — Telix Pharmaceuticals Ltd. has announced a strategic clinical collaboration with Varian, a Siemens ...

Time December 11, 2025
arrow
Subscribe Now